Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

(MedPage Today) -- Mepolizumab (Nucala) improved outcomes for adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and put about one in five on the way to remission, a real-life study from Italy showed.
The nasal polyp score dropped...